11th Jun 2021 09:56
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 10 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
5,817,191 | 2.31% | 131,274 | 0.05% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
82,054 | 0.03% | 5,206,731 | 2.07% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
5,899,245 | 2.34% | 5,338,005 | 2.12% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 191 | 10.4607 GBP |
Purchase | 202 | 10.4800 GBP |
Purchase | 861 | 10.4696 GBP |
Purchase | 861 | 10.4700 GBP |
Purchase | 1,498 | 10.4900 GBP |
Purchase | 6,034 | 10.4864 GBP |
Purchase | 6,399 | 10.4879 GBP |
Purchase | 10,714 | 10.4903 GBP |
Purchase | 18,312 | 10.5100 GBP |
Purchase | 33,119 | 10.4852 GBP |
Purchase | 36,442 | 10.4989 GBP |
Purchase | 37,555 | 10.4851 GBP |
Purchase | 149,436 | 10.4829 GBP |
Purchase | 162,941 | 10.4913 GBP |
Sale | 532 | 10.4900 GBP |
Sale | 763 | 10.4814 GBP |
Sale | 852 | 10.4799 GBP |
Sale | 861 | 10.4710 GBP |
Sale | 861 | 10.4700 GBP |
Sale | 941 | 10.4906 GBP |
Sale | 1,224 | 10.4800 GBP |
Sale | 1,471 | 10.5250 GBP |
Sale | 1,976 | 10.4806 GBP |
Sale | 2,089 | 10.4896 GBP |
Sale | 2,189 | 10.4765 GBP |
Sale | 3,310 | 10.4883 GBP |
Sale | 3,325 | 10.4970 GBP |
Sale | 6,055 | 10.5105 GBP |
Sale | 8,889 | 10.4744 GBP |
Sale | 9,300 | 10.5008 GBP |
Sale | 9,512 | 10.4984 GBP |
Sale | 10,218 | 10.4849 GBP |
Sale | 11,555 | 10.4808 GBP |
Sale | 11,977 | 10.4898 GBP |
Sale | 17,857 | 10.4892 GBP |
Sale | 21,772 | 10.5100 GBP |
Sale | 25,845 | 10.4876 GBP |
Sale | 215,428 | 10.4854 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
SWAP | Long | 4,420 | 10.4736 GBP |
CFD | Long | 7,058 | 10.4585 GBP |
SWAP | Long | 12,543 | 10.4818 GBP |
CFD | Short | 260 | 10.4714 GBP |
CFD | Short | 10,714 | 10.4903 GBP |
SWAP | Short | 15,414 | 10.4836 GBP |
SWAP | Short | 16,537 | 10.4835 GBP |
SWAP | Short | 22,394 | 10.4890 GBP |
SWAP | Short | 30,000 | 10.4852 GBP |
SWAP | Short | 36,442 | 10.4989 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 11 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210611005160/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L